Characteristics and Clinical Outcomes of Critically Ill Cancer Patients Admitted to Korean Intensive Care Units
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The objective of this study was to investigate the characteristics and clinical outcomes of critically ill cancer patients admitted to intensive care units (ICUs) in Korea. Methods: This was a retrospective cohort study that analyzed prospective collected data from the Validation of Simplified Acute Physiology Score 3 (SAPS3) in Korean ICU (VSKI) study, which is a nationwide, multicenter, and prospective study that considered 5,063 patients from 22 ICUs in Korea over a period of 7 months. Among them, patients older than 18 years of age who were diagnosed with solid or hematologic malignancies prior to admission to the ICU were included in the present study. Results: During the study period, a total of 1,762 cancer patients were admitted to the ICUs and 833 of them were deemed eligible for analysis. Six hundred fifty-eight (79%) had solid tumors and 175 (21%) had hematologic malignancies, respectively. Respiratory problems (30.1%) was the most common reason leading to ICU admission. Patients with hematologic malignancies had higher Sequential Organ Failure Assessment (12 vs. 8, P<0.001) and SAPS3 (71 vs. 69, P<0.001) values and were more likely to be associated with chemotherapy, steroid therapy, and immunocompromised status versus patients with solid tumors. The use of inotropes/vasopressors, mechanical ventilation, and/or continuous renal replacement therapy was more frequently required in hematologic malignancy patients. Mortality rates in the ICU (41.7% vs. 24.6%, P<0.001) and hospital (53.1% vs. 38.6%, P=0.002) were higher in hematologic malignancy patients than in solid tumor patients. Conclusions: Cancer patients accounted for one-third of all patients admitted to the studied ICUs in Korea. Clinical characteristics were different according to the type of malignancy. Patients with hematologic malignancies had a worse prognosis than did patients with solid tumor.
Abstract
Background: The objective of this study was to investigate the characteristics and clinical outcomes of critically ill cancer patients admitted to intensive care units (ICUs) in Korea. Methods: This was a retrospective cohort study that analyzed prospective collected data from the Validation of Simplified Acute Physiology Score 3 (SAPS3) in Korean ICU (VSKI) study, which is a nationwide, multicenter, and prospective study that considered 5,063 patients from 22 ICUs in Korea over a period of 7 months. Among them, patients older than 18 years of age who were diagnosed with solid or hematologic malignancies prior to admission to the ICU were included in the present study. Results: During the study period, a total of 1,762 cancer patients were admitted to the ICUs and 833 of them were deemed eligible for analysis. Six hundred fifty-eight (79%) had solid tumors and 175 (21%) had hematologic malignancies, respectively. Respiratory problems (30.1%) was the most common reason leading to ICU admission. Patients with hematologic malignancies had higher Sequential Organ Failure Assessment (12 vs. 8, P<0.001) and SAPS3 (71 vs. 69, P<0.001) values and were more likely to be associated with chemotherapy, steroid therapy, and immunocompromised status versus patients with solid tumors. The use of inotropes/vasopressors, mechanical ventilation, and/or continuous renal replacement therapy was more frequently required in hematologic malignancy patients. Mortality rates in the ICU (41.7% vs. 24.6%, P<0.001) and hospital (53.1% vs. 38.6%, P=0.002) were higher in hematologic malignancy patients than in solid tumor patients. Conclusions: Cancer patients accounted for one-third of all patients admitted to the studied ICUs in Korea. Clinical characteristics were different according to the type of malignancy. Patients with hematologic malignancies had a worse prognosis than did patients with solid tumor.
참고문헌 (28)
- van Vliet M, "Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units", Intensive Care Med, 40, pp.1275~1284 (2014)[DOI]
- Garrouste-Orgeas M, "Predictors of intensive care unit refusal in French intensive care units: a multiple-center study", Crit Care Med, 33, pp.750~755 (2005)[DOI]
- Schuster DP, "Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematologic malignancy", Am J Med, 75, pp.402~408 (1983)[DOI]
- Jackson SR, "Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors", Bone Marrow Transplant, 21, pp.697~704 (1998)[DOI]
- Soares M, "Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study", Crit Care Med, 38, pp.9~15 (2010)[DOI]
- Azoulay E, "Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium. A groupe de recherche respiratoire en reanimation onco-hematologique study", J Clin Oncol, 31, pp.2810~2818 (2013)[DOI]
- Torre LA, "Global cancer incidence and mortality rates and trends: an update", Cancer Epidemiol Biomarkers Prev, 25, pp.16~27 (2016)[DOI]
- Lim SY, "Validation of SAPS3 admission score and its customization for use in Korean intensive care unit patients: a prospective multicentre study", Respirology, 18, pp.989~995 (2013)[DOI]
- Metnitz PG, "SAPS 3: from evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description", Intensive Care Med, 31, pp.1336~1344 (2005)[DOI]
- Levy MM, "2001 SCCM", ESICM, ATS, pp.SIS International Sepsis Definitions Conference, Crit Care Med[DOI]
- Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol, 5, pp.649~655 (1982)[DOI]
- Moreno RP, "SAPS 3: from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission", Intensive Care Med, 31, pp.1345~1355 (2005)[DOI]
- Staudinger T, "Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit", Crit Care Med, 28, pp.1322~1328 (2000)[DOI]
- Bos MM, "Outcomes of cancer patients after unplanned admission to general intensive care units", Acta Oncol, 51, pp.897~905 (2012)[DOI]
- Darmon M, "Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy", Crit Care Med, 33, pp.2488~2493 (2005)[DOI]
- Hawari FI, "Predictors of ICU admission in patients with cancer and the related characteristics and outcomes: a 5-year registry-based study", Crit Care Med, 44, pp.548~553 (2016)
- Chi AK, "An update on pulmonary complications of hematopoietic stem cell transplantation", Chest, 144, pp.1913~1922 (2013)[DOI]
- Pastores SM, "Acute respiratory failure in the patient with cancer: diagnostic and management strategies", Crit Care Clin, 26, pp.21~40 (2010)[DOI]
- Bhatt V, "Review: drug-induced neutropenia. Pathophysiology, clinical features, and management", Ann Clin Lab Sci, 34, pp.131~137 (2004)
- Bodey GP, "Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia", Ann Intern Med, 64, pp.328~340 (1966)[DOI]
- Puxty K, "Risk of critical illness among patients with solid cancers: a population-based observational study", JAMA Oncol, 1, pp.1078~1085 (2015)[DOI]
- Depuydt PO, "Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure", Chest, 126, pp.1299~1306 (2004)[DOI]
- Platon L, "A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013)", Bone Marrow Transplant, 51, pp.256~261 (2016)[DOI]
- Depuydt P, "Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience", Bone Marrow Transplant, 46, pp.1186~1191 (2011)[DOI]
- Azevedo LC, "Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study", Chest, 146, pp.257~266 (2014)[DOI]
- Pene F, "Outcome of critically ill allogeneic hematopoietic stemcell transplantation recipients: a reappraisal of indications for organ failure supports", J Clin Oncol, 24, pp.643~649 (2006)[DOI]
- Soares M, "Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs", Crit Care Med, 33, pp.520~526 (2005)[DOI]
- Peigne V, "Continued survival gains in recent years among critically ill myeloma patients", Intensive Care Med, 35, pp.512~518 (2009)[DOI]